NeuroVive’s Board Members and Senior Executives subscribe to shares in the ongoing rights issue

In the ongoing rights issue in NeuroVive, the Board and Senior Executives have undertaken to subscribe for at least 446,176 shares.

The subscription period will continue until 29 April, 2020, and is open to both existing and new investors.

Read more about the rights issue at

Prospectus (in Swedish), containing full terms and conditions, as well as application forms are available on NeuroVive’s website, and on Erik Penser Bank’s website